UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

Husein, Melisa; Petignat, Patrick; Cohen, Marie-Benoîte

doi:10.18632/oncoscience.575

Scientific article

Editorial

English

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

ContributorsHusein, Melisa; Petignat, Patrick; Cohen, Marie-Benoîte

Published inOncoscience, vol. 10, p. 9-10

Publication date2023-05-11

Keywords

Drug resistance
Ovarian cancer
Polyploidy giant cancer cell
Unfolded protein response

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Research groups

Citation (ISO format)

HUSEIN, Melisa, PETIGNAT, Patrick, COHEN, Marie-Benoîte. UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance? In: Oncoscience, 2023, vol. 10, p. 9–10. doi: 10.18632/oncoscience.575

Article (Published version)

CC BY-3.0

Identifiers

PID : unige:172859
DOI : 10.18632/oncoscience.575
PMID : 37182093
PMCID : PMC10174630

Additional URL for this publicationhttps://www.oncoscience.us/lookup/doi/10.18632/oncoscience.575

Journal ISSN2331-4737

115views

39downloads

Creation19/07/2023 14:52:59

First validation13/11/2023 08:51:43

Update time13/11/2023 08:51:43

Status update13/11/2023 08:51:43

Last indexation01/11/2024 06:39:44

Archive ouverte UNIGE

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

Technical informations